| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,636 |
10,902 |
$472K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,435 |
3,009 |
$179K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,680 |
1,379 |
$18K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
138 |
125 |
$8K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
373 |
240 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
279 |
146 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
73 |
71 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
27 |
27 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
52 |
38 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
984 |
847 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
32 |
31 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
475 |
437 |
$1K |
| 80305 |
|
101 |
98 |
$859.20 |
| 90688 |
|
74 |
62 |
$550.29 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
32 |
29 |
$502.37 |
| 90686 |
|
59 |
55 |
$356.41 |
| 90619 |
|
21 |
21 |
$316.12 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
442 |
370 |
$82.48 |
| 3079F |
|
86 |
78 |
$20.00 |
| 3077F |
|
74 |
62 |
$15.00 |
| 90461 |
|
69 |
46 |
$0.00 |
| 90734 |
|
14 |
13 |
$0.00 |
| 3074F |
|
40 |
40 |
$0.00 |